CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis

Clinical trial NCT02629419 · COMPLETED

Trial details

NCT number: NCT02629419
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Candidiasis, Chronic Mucocutaneous

Start date: 2016-09-27
Primary completion: 2021-11-09
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.